Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 8

1.

DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene.

Ceccherini I, Hofstra RM, Luo Y, Stulp RP, Barone V, Stelwagen T, Bocciardi R, Nijveen H, Bolino A, Seri M, et al.

Oncogene. 1994 Oct;9(10):3025-9. Erratum in: Oncogene. 1995 Mar 16;10(6):1257.

PMID:
8084609
2.

RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series.

Fugazzola L, Muzza M, Mian C, Cordella D, Barollo S, Alberti L, Cirello V, Dazzi D, Girelli ME, Opocher G, Beck-Peccoz P, Persani L.

Clin Endocrinol (Oxf). 2008 Sep;69(3):418-25. doi: 10.1111/j.1365-2265.2008.03218.x. Epub 2008 Feb 11.

PMID:
18284634
3.

Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?

Baumgartner-Parzer SM, Lang R, Wagner L, Heinze G, Niederle B, Kaserer K, Waldhäusl W, Vierhapper H.

J Clin Endocrinol Metab. 2005 Nov;90(11):6232-6. Epub 2005 Aug 23.

PMID:
16118333
4.

Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.

Cebrian A, Lesueur F, Martin S, Leyland J, Ahmed S, Luccarini C, Smith PL, Luben R, Whittaker J, Pharoah PD, Dunning AM, Ponder BA.

J Clin Endocrinol Metab. 2005 Nov;90(11):6268-74. Epub 2005 Aug 9.

PMID:
16091499
5.

The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.

Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA, Niederle B.

Thyroid. 2008 Dec;18(12):1269-76. doi: 10.1089/thy.2008.0139.

PMID:
18976163
6.
7.

Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A.

Robledo M, Gil L, Pollán M, Cebrián A, Ruíz S, Azañedo M, Benitez J, Menárguez J, Rojas JM.

Cancer Res. 2003 Apr 15;63(8):1814-7.

8.

Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation.

Gimm O, Neuberg DS, Marsh DJ, Dahia PL, Hoang-Vu C, Raue F, Hinze R, Dralle H, Eng C.

Oncogene. 1999 Feb 11;18(6):1369-73.

Supplemental Content

Support Center